What is LSPediA?
Founded in 2013, LSPediA is a prominent global provider of comprehensive solutions for compliance, serialization, traceability, business intelligence, and supply chain management. The company's flagship OneScan Suite is recognized as a leading platform for meeting the stringent requirements of the Drug Supply Chain Security Act (DSCSA). Furthermore, its Investigator software offers an automated, collaborative approach to efficiently resolve pharmaceutical transaction data and logistics exceptions in real time, enhancing operational efficiency and regulatory adherence for its clients.
How much funding has LSPediA raised?
LSPediA has raised a total of $357K across 2 funding rounds:
Debt
$150K
Debt
$207K
Debt (2020): $150K with participation from PPP
Debt (2021): $207K led by PPP
What's next for LSPediA?
The substantial capital infusion, characterized as a large-scale late-stage funding event, signals LSPediA's readiness for accelerated expansion and strategic market penetration. This investment is likely to fuel further development of its innovative compliance and traceability technologies, enhance its global operational footprint, and potentially support strategic acquisitions. The company is well-positioned to capitalize on the increasing demand for robust pharmaceutical supply chain security and regulatory compliance solutions.
See full LSPediA company page
